FDA Issues Kidney Warning for Four Diabetes Drugs
The Food and Drug Administration (FDA) of the United States has issued a warning that four common diabetes drugs may cause potentially life-threatening harm. Canaglflozin, sold by Janssen Pharmaceuticals as Invokana and Invokamet and dapagliflozin, sold by AstraZeneca as Farxiga ...
Read More »
Recent Comments